SODIUM ACETATE INJECTION, USP 200 mEq/100 mL (2 mEq/mL)

Manufacturer
Exela Pharma Sciences, LLC
Effective date
2022-06-16
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:57:36

Label at a glance#

ProductSodium Acetate
Active ingredientSODIUM ACETATE ANHYDROUS
Label structure2 sections

Dosage and administration

Sodium Acetate Injection, USP (2 mEq/mL) is administered intravenously only after dilution in a larger volume of fluid. The dose and rate of administration are dependent upon the individual needs of the patient. Serum sodium should be monitored as a guide to dosage. Using aseptic technique, all or part of the contents of one or more vials may be added to other intravenous fluids to provide any desired number of mi...

Label contents#

Full prescribing information#

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Sodium Acetate Injection, USP (2 mEq/mL) is administered intravenously only after dilution in a larger volume of fluid. The dose and rate of administration are dependent upon the individual needs of the patient. Serum sodium should be monitored as a guide to dosage. Using aseptic technique, all or part of the contents of one or more vials may be added to other intravenous fluids to provide any desired number of milliequivalents (mEq) of sodium (Na+) with an equal number of acetate (CH3COO−).

Sodium Acetate Injection, USP (2 mEq/mL) in the Pharmacy Bulk Package is designed for use with manual, gravity flow operations and automated compounding devices for preparing intravenous nutritional admixtures. Admixtures must be stored under refrigeration and used within 24 hours after compounding.

A single entry through the vial closure should be made with a sterile dispensing set or transfer device. Transfer individual doses to appropriate intravenous infusion solutions. Use of a syringe with a needle is not recommended. The above process should be carried out under a laminar flow hood using aseptic technique.

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Vial Label
Vial Label

SODIUM ACETATE INJECTION, USP

NDC 51754-9995-1

200 mEq/100 mL (2 mEq/mL) Rx Only

Pharmacy Bulk Package. Not for Direct Infusion.

CAUTION: MUST BE DILUTED

FOR INTRAVENOUS USE ONLY. PRESERVATIVE FREE.

Sterile, Nonpyrogenic Use only if solution is clear and seal is intact.

Volume: 100 mL/Vial

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51754-999551754-9995-1, 51754-9995-5

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
SODIUM ACETATE ANHYDROUSNVG71ZZ7P0ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
811e32a7-df1a-485d-8ac8-5bc92223890ee11ab1a1-8cc7-4d3b-ad29-af4c9aaa3ed42022-06-16Exact identifier
spl set id: e11ab1a1-8cc7-4d3b-ad29-af4c9aaa3ed4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.